Effects of Melatonin as a Novel Antioxidant and Free Radicals Scavenger in Neonatal Sepsis
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
Assess the efficacy of melatonin as an adjuvant in the treatment of free radical disease in
septic preterms receiving melatonin compared to those on conventional treatment through
measuring the level of Malondialdehyde as a marker of oxidative stress and by comparing other
clinical and laboratory parameters of sepsis in both groups.